Litemed
PrivateLast Round
Early Funding
Feb 10, 2026
Total Funding Raised
$2.2M
Company Overview
Litemed is a medical technology company that develops non-invasive, wearable photobiomodulation devices for pain management.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, D2C Brands
Business Model
B2C
Customer Profile
Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Litemed Comparables
Compare Litemed with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Recharge Health | 88% | |
| CareWear Corp. | 86% | |
| DNA Vibe | 85% | |
Litemed Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Feb 10, 2026 |
Key People
Founding team and executive leadership
Litemed Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ideaspring Capital | Early Funding |
| V3 Ventures | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 6, 2025
Grew 33% QoQ from 21 to 28 employees.
- Apr 12, 2025
Grew 56% QoQ, from 18 to 28 employees.
Litemed Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Litemed's valuation, stock price, and market status.